Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma.
第一作者:
Marcelo Lima,Ribeiro
第一单位:
Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
作者:
主题词
动物(Animals);人类(Humans);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);小鼠(Mice);哌啶类(Piperidines);蛋白激酶抑制剂(Protein Kinase Inhibitors);吡唑类(Pyrazoles);嘧啶类(Pyrimidines);信号传导(Signal Transduction)
DOI
10.1158/1078-0432.CCR-21-1067
PMID
34551904
发布时间
2023-01-06
- 浏览0

Clinical cancer research
6591-6601页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文